Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 1, 2011, Pages 65-72

  Ringden, O ^a   Le Blanc, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Hemorrhagic cystitis; Mesenchymal stem cells; Tissue toxicity

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; CYCLOSPORIN; FRESH FROZEN PLASMA; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHOTREXATE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROCHYMAL; RAPAMYCIN; RECOMBINANT INTERLEUKIN 1; STEROID; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; COLON PERFORATION; ERYTHROCYTE TRANSFUSION; GASTROENTERITIS; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT VERSUS LEUKEMIA EFFECT; HEMORRHAGIC CYSTITIS; HLA SYSTEM; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INBORN ERROR OF METABOLISM; LEUKEMIA; LIVER TOXICITY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUCOSA INFLAMMATION; NONHUMAN; ORGAN DONOR; PERITONITIS; PNEUMOMEDIASTINUM; PNEUMONIA; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; VASOCONSTRICTION; WHOLE BODY RADIATION; WOUND HEALING;

EID: 79952583181     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2011.01.003     Document Type: Review

References (69)

1. O. Ringden, M. Remberger, and B.M. Svahn Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center Transplantation 81 2006 718 725
2. R. Storb, E.D. Thomas, and P.L. Weiden Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle Blood 48 1976 817 841
3. E.D. Thomas, C.D. Buckner, and M. Banaji One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation Blood 49 1977 511 533 (Pubitemid 8080182)
4. O. Ringden, and H.J. Deeg Clinical spectrum of graft-versus-host disease J.L.M. Ferrara, H.J. Deeg, S. Burakoff, Graft vs host disease ed. 2nd 1996 Marcel Dekker, Inc New York 525 559
5. R. Storb, and E.D. Thomas Graft-versus-host disease in dog and man: the seattle experience Immunol Rev. 88 1985 215 238 (Pubitemid 16172498)
6. J.L. Ferrara, R. Levy, and N.J. Chao Pathophysiologic mechanisms of acute graft-vs.-host disease Biol Blood Marrow Transplant 5 1999 347 356
7. A.M. Marmont, M.M. Horowitz, and R.P. Gale T-cell depletion of HLA-identical transplants in leukemia Blood 78 1991 2120 2130
8. H.G. Prentice, H.A. Blacklock, and G. Janossy Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients Lancet 1 1984 472 476 (Pubitemid 14193138)
9. O. Ringden, M.M. Horowitz, and P. Sondel Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 81 1993 1094 1101 (Pubitemid 23054851)
10. R. Storb, H.J. Deeg, and M. Pepe Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial Blood 73 1989 1729 1734 (Pubitemid 19131924)
11. C. Anasetti, J.A. Hansen, and T.A. Waldmann Treatment of acute graft-versus-host disease with humanized anti-tac: an antibody that binds to the interleukin-2 receptor Blood 84 1994 1320 1327 (Pubitemid 24245902)
12. A.I. Benito, T. Furlong, and P.J. Martin Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease Transplantation 72 2001 1924 1929 (Pubitemid 34027865)
13. H.J. Deeg, B.R. Blazar, and B.J. Bolwell Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL Blood 98 2001 2052 2058
14. P. Herve, J. Wijdenes, and J.P. Bergerat Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) Blood 75 1990 1017 1023 (Pubitemid 20067205)
15. G. Kobbe, P. Schneider, and U. Rohr Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody Bone Marrow Transplant 28 2001 47 49 (Pubitemid 32707616)
16. M. Remberger, J. Aschan, and L. Barkholt Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin Clin Transplant 15 2001 147 153 (Pubitemid 32487439)
17. K.M. Sullivan, H.M. Shulman, and R. Storb Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression Blood 57 1981 267 276 (Pubitemid 11174888)
18. M.R. Canninga-van Dijk, H.M. van der Straaten, and R. Fijnheer Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Blood 104 2004 2603 2606 (Pubitemid 39331867)
19. M.E. Flowers, J.F. Apperley, and K. van Besien A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease Blood 112 2008 2667 2674
20. H.T. Greinix, B. Volc-Platzer, and P. Kalhs Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study Blood 96 2000 2426 2431
21. S. Koc, W. Leisenring, and M.E. Flowers Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone Blood 100 2002 48 51 (Pubitemid 35177427)
22. G. Socie, A. Devergie, and J.M. Cosset Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease Transplantation 49 1990 657 658 (Pubitemid 20110496)
23. M.M. Horowitz, R.P. Gale, and P.M. Sondel Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555 562 (Pubitemid 20069191)
24. O. Ringden, H. Karlsson, and R. Olsson The allogeneic graft-versus-cancer effect Br J Haematol 147 2009 614 633
25. P.L. Weiden, N. Flournoy, and E.D. Thomas Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts N Engl J Med 300 1979 1068 1073 (Pubitemid 9198740)
26. K. Le Blanc, and O. Ringden Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation Biol Blood Marrow Transplant 11 2005 321 334 (Pubitemid 40542924)
27. A. Bartholomew, C. Sturgeon, and M. Siatskas Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp Hematol 30 2002 42 48 (Pubitemid 34059216)
28. K. Le Blanc, L. Tammik, and B. Sundberg Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand J Immunol 57 2003 11 20 (Pubitemid 38019084)
29. W.T. Tse, J.D. Pendleton, and W.M. Beyer Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 2003 389 397 (Pubitemid 36222968)
30. I. Rasmusson, O. Ringden, and B. Sundberg Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells Transplantation 76 2003 1208 1213 (Pubitemid 37339646)
31. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822 (Pubitemid 40223708)
32. M. Di Nicola, C. Carlo-Stella, and M. Magni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843 (Pubitemid 34534559)
33. R. Meisel, A. Zibert, and M. Laryea Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621 (Pubitemid 38745993)
34. I. Rasmusson, O. Ringden, and B. Sundberg Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms Exp Cell Res. 305 2005 33 41 (Pubitemid 40380651)
35. O.N. Koc, S.L. Gerson, and B.W. Cooper Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy J Clin Oncol 18 2000 307 316 (Pubitemid 30056419)
36. O.N. Koc, C. Peters, and P. Aubourg Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases Exp Hematol 27 1999 1675 1681 (Pubitemid 29526752)
37. H.M. Lazarus, S.E. Haynesworth, and S.L. Gerson Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use Bone Marrow Transplant 16 1995 557 564
38. K. Le Blanc, I. Rasmusson, and B. Sundberg Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441 (Pubitemid 38586721)
39. O. Ringden, M. Uzunel, and I. Rasmusson Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease Transplantation 81 2006 1390 1397 (Pubitemid 43847148)
40. O. Ringden, and K. Le Blanc Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells Biol Blood Marrow Transplant 12 2006 693 694
41. K. Le Blanc, F. Frassoni, and L. Ball Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 2008 1579 1586 (Pubitemid 351626841)
42. B. Fang, Y. Song, and L. Liao Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease Transplant Proc. 39 2007 3358 3362 (Pubitemid 350251475)
43. S.-J. Ho, P. Dyson, and T. Rawling Mesenchymal stem cells for treatment of steroid-resistant graft-versus-host disease Biol Blood Marrow Transplant 13 2007 46 47
44. P. Kebriaei, L. Isola, and E. Bahceci Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease Biol Blood Marrow Transplant 15 2009 804 811
45. M. von Bonin, F. Stolzel, and A. Goedecke Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium Bone Marrow Transplant 43 2009 245 251
46. G. Lucchini, M. Introna, and E. Dander Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population Biol Blood Marrow Transplant 16 2010 1293 1301
47. V.K. Prasad, K.G. Lucas, and G.I. Kleiner Efficacy and safety of ex-vivo cultured adult human mesenchymal stem cells (prochymal(TM)) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study Biol Blood Marrow Transplant 2010, May 7 [Epub ahead of print]
48. K.M. Sullivan, R.P. Witherspoon, and R. Storb Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 72 1988 546 554
49. S.Z. Pavletic, P. Martin, and S.J. Lee Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV Biol Blood Marrow Transplant 12 2006 252 266 Response Criteria Working Group report (Pubitemid 43273710)
50. M.A. Gonzalez, E. Gonzalez-Rey, and L. Rico Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses Gastroenterology 136 2009 978 989
51. B. Parekkadan, A.W. Tilles, and M.L. Yarmush Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells Stem Cells 26 2008 1913 1919
52. L. Sun, K. Akiyama, and H. Zhang Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans Stem Cells 27 2009 1421 1432
53. E. Zappia, S. Casazza, and E. Pedemonte Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761 (Pubitemid 41208591)
54. K. Atkinson, V. Farewell, and R. Storb Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease Blood 60 1982 714 720 (Pubitemid 12027152)
55. O. Ringden, T. Paulin, and B. Lonnqvist An analysis of factors predisposing to chronic graft-versus-host disease Exp Hematol 13 1985 1062 1067 (Pubitemid 16172301)
56. R. Storb, R.L. Prentice, and K.M. Sullivan Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings Ann Intern Med 98 1983 461 466 (Pubitemid 13116613)
57. Ringden O, Keating A. Mesenchymal stem cells as treatment for chronic graft-versus-host disease. Bone Marrow Transplant. in press.
58. H. Zhou, M. Guo, and C. Bian Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report Biol Blood Marrow Transplant 16 2010 403 412
59. J. Weng, X. Du, and S. Geng Mesenchymal stem cell as salvage treatment for refractory chronic graft-versus-host disease Bone Marrow Transplant 6 September 2010 E-pub ahead of print
60. M.S. Tsoi, R. Storb, and E. Jones Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man J Immunol 120 1978 1485 1492 (Pubitemid 8400378)
61. A. Corcione, F. Benvenuto, and E. Ferretti Human mesenchymal stem cells modulate B-cell functions Blood 107 2006 367 372 (Pubitemid 43053565)
62. S. Beyth, Z. Borovsky, and D. Mevorach Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219 (Pubitemid 40731815)
63. I. Rasmusson, K. Le Blanc, B. Sundberg, and O. Ringden Mesenchymal stem cells stimulate antibody secretion in human B cells Scand J Immunol 65 2007 336 343 (Pubitemid 46481102)
64. O. Ringden, M. Uzunel, and B. Sundberg Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon Leukemia 21 2007 2271 2276 (Pubitemid 350011699)
65. Z. Hassan, M. Remberger, and P. Svenberg Hemorrhagic cystitis: a retrospective single-center survey Clin Transplant 21 2007 659 667 (Pubitemid 47399432)
66. H. Samuelsson, O. Ringden, H. Lonnies, and K. Le Blanc Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells Cytotherapy 11 2009 129 136
67. Ringden O, Le Blanc K. Pooled mesenchymal stem cells for treatment of severe hemorrhages. Bone Marrow Transplant, in press.
68. H. Ning, F. Yang, and M. Jiang The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study Leukemia 22 2008 593 599 (Pubitemid 351386730)
69. H. Karlsson, S. Samarasinghe, and L.M. Ball Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses Blood 112 2008 532 541